Repare Therapeutics (RPTX) Short Interest Ratio & Short Volume → America’s worst nightmare? (From Porter & Company) (Ad) Free RPTX Stock Alerts $3.69 -0.01 (-0.27%) (As of 05/14/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Repare Therapeutics Short Interest DataCurrent Short Volume682,500 sharesPrevious Short Volume608,300 sharesChange Vs. Previous Month+12.20%Dollar Volume Sold Short$2.12 millionShort Interest Ratio / Days to Cover3.5Last Record DateApril 30, 2024Outstanding Shares42,440,000 sharesFloat Size28,690,000 sharesShort Percent of Float2.38%Today's Trading Volume254,879 sharesAverage Trading Volume201,664 sharesToday's Volume Vs. Average126% Short Selling Repare Therapeutics ? Sign up to receive the latest short interest report for Repare Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRPTX Short Interest Over TimeRPTX Days to Cover Over TimeRPTX Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Repare Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024682,500 shares $2.12 million +12.2%2.4%3.5 $3.10 4/15/2024608,300 shares $2.11 million -10.7%2.1%4.7 $3.47 3/31/2024681,000 shares $3.21 million +3.4%2.4%4.6 $4.71 3/15/2024658,600 shares $3.48 million -11.4%2.3%4.2 $5.29 2/29/2024743,300 shares $5.17 million -8.5%2.6%3.7 $6.95 2/15/2024812,500 shares $5.65 million -52.8%2.8%3.6 $6.95 Get the Latest News and Ratings for RPTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Repare Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,720,000 shares $11.25 million -20.0%5.4%5.7 $6.54 1/15/20242,150,000 shares $14.06 million -2.7%6.8%6 $6.54 12/31/20232,210,000 shares $16.13 million -12.3%7.0%5.9 $7.30 12/15/20232,520,000 shares $17.01 million -7.4%7.9%6.9 $6.75 11/30/20232,720,000 shares $14.01 million +25.9%8.6%7.8 $5.15 11/15/20232,160,000 shares $11.43 million +24.1%6.8%6.9 $5.29 10/31/20231,740,000 shares $5.92 million +10.8%5.5%7.4 $3.40 10/15/20231,570,000 shares $8.29 million +23.6%4.9%9.9 $5.28 9/30/20231,270,000 shares $15.34 million +1.6%4.0%10.8 $12.08 9/15/20231,250,000 shares $12.90 million +4.2%3.9%12.3 $10.32 8/31/20231,200,000 shares $11.71 million -3.2%3.8%12.5 $9.76 8/15/20231,240,000 shares $12.05 million +0.8%3.9%12.1 $9.72 7/31/20231,230,000 shares $11.32 million -5.4%3.9%12.6 $9.20 7/15/20231,300,000 shares $14.14 million +2.4%4.1%13.7 $10.88 6/30/20231,270,000 shares $13.44 million -5.9%4.0%12.4 $10.58 6/15/20231,350,000 shares $16.67 million +7.1%4.3%13 $12.35 5/31/20231,260,000 shares $13.37 million -2.3%4.0%12.2 $10.61 5/15/20231,290,000 shares $13.08 million -4.4%4.1%12.8 $10.14 4/30/20231,350,000 shares $12.10 million -12.9%4.3%12 $8.96 4/15/20231,550,000 shares $14.06 million -8.3%5.0%12.6 $9.07 3/31/20231,690,000 shares $16.63 million +1.2%5.4%13.4 $9.84 3/15/20231,670,000 shares $16.60 million +6.4%5.4%11.6 $9.94 2/28/20231,570,000 shares $16.09 million +4.0%5.1%9.7 $10.25 2/15/20231,510,000 shares $17.41 million +4.9%4.9%9.2 $11.53 1/31/20231,440,000 shares $17.80 million -7.1%4.7%7.7 $12.36 1/15/20231,550,000 shares $19.92 million +22.1%5.0%8.8 $12.85 12/30/20221,270,000 shares $18.68 million +64.2%4.1%7.5 $14.71 12/15/2022773,300 shares $11.55 million -39.6%2.5%4.9 $14.93 11/30/20221,280,000 shares $20.52 million -18.0%4.2%8.9 $16.03 11/15/20221,560,000 shares $26.69 million +0.7%5.1%11.7 $17.11 10/31/20221,550,000 shares $23.34 million -1.9%5.1%12.6 $15.06 10/15/20221,580,000 shares $21.09 million -1.9%5.2%10.8 $13.35 9/30/20221,610,000 shares $19.53 million +4.6%5.3%10.5 $12.13 9/15/20221,540,000 shares $20.14 million -4.4%5.0%9.1 $13.08America’s worst nightmare? (Ad)What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now. RPTX Short Interest - Frequently Asked Questions What is Repare Therapeutics' current short interest? Short interest is the volume of Repare Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 682,500 shares of RPTX short. 2.38% of Repare Therapeutics' shares are currently sold short. Learn More on Repare Therapeutics' current short interest. What is a good short interest ratio for Repare Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RPTX shares currently have a short interest ratio of 4.0. Learn More on Repare Therapeutics's short interest ratio. What is a good short interest percentage for Repare Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.38% of Repare Therapeutics' floating shares are currently sold short. Is Repare Therapeutics' short interest increasing or decreasing? Repare Therapeutics saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 682,500 shares, an increase of 12.2% from the previous total of 608,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Repare Therapeutics' float size? Repare Therapeutics currently has issued a total of 42,440,000 shares. Some of Repare Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Repare Therapeutics currently has a public float of 28,690,000 shares. How does Repare Therapeutics' short interest compare to its competitors? 2.38% of Repare Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Repare Therapeutics: DiaMedica Therapeutics Inc. (0.48%), PDS Biotechnology Co. (18.70%), Sagimet Biosciences Inc. (12.78%), Syros Pharmaceuticals, Inc. (7.79%), FibroGen, Inc. (6.96%), Adicet Bio, Inc. (9.35%), Amylyx Pharmaceuticals, Inc. (18.07%), Regulus Therapeutics Inc. (7.33%), Nuvectis Pharma, Inc. (13.15%), InterCure Ltd. (0.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Repare Therapeutics stock? Short selling RPTX is an investing strategy that aims to generate trading profit from Repare Therapeutics as its price is falling. RPTX shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Repare Therapeutics? A short squeeze for Repare Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RPTX, which in turn drives the price of the stock up even further. How often is Repare Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RPTX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: DMAC Short Interest Data PDSB Short Interest Data SGMT Short Interest Data SYRS Short Interest Data FGEN Short Interest Data ACET Short Interest Data AMLX Short Interest Data RGLS Short Interest Data NVCT Short Interest Data INCR Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RPTX) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersDid Intel Just Dethrone Nvidia?Chaikin AnalyticsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsCharles Payne Demystifies OptionsUnstoppable ProsperityThe only AI company you should be looking atBehind the MarketsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperElon to Transform U.S. Economy? Porter & Company